It would be the first therapy to alter a person’s genes to treat disease. If approved, which seems highly likely given the agency’s preliminary recommendation, the therapy would treat only one particular disease, a blood cancer called acute lymphoblastic leukemia (ALL). But with more research, this type of therapy has the potential to treat a variety of cancers. Read more . . .
Yesterday, the Food and Drug Administration recommended a brand new type of cancer treatment for approval: One that employs the body’s immune system—a method known as immunotherapy—to fight cancer.